nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base
|
McCloskey, E. |
|
2015 |
27 |
1 |
p. 417-419 |
artikel |
2 |
Abnormal subchondral bone microstructure following steroid administration is involved in the early pathogenesis of steroid-induced osteonecrosis
|
Wang, L. |
|
2015 |
27 |
1 |
p. 153-159 |
artikel |
3 |
Alkaline biodegradable implants for osteoporotic bone defects—importance of microenvironment pH
|
Liu, W. |
|
2015 |
27 |
1 |
p. 93-104 |
artikel |
4 |
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study
|
Brozek, W. |
|
2015 |
27 |
1 |
p. 387-396 |
artikel |
5 |
A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates
|
Cosman, F. |
|
2015 |
27 |
1 |
p. 377-386 |
artikel |
6 |
Association between prolonged breastfeeding and bone mineral density and osteoporosis in postmenopausal women: KNHANES 2010-2011
|
Hwang, I. R. |
|
2015 |
27 |
1 |
p. 257-265 |
artikel |
7 |
Bone remodeling markers: so easy to measure, so difficult to interpret
|
Seeman, E. |
|
2015 |
27 |
1 |
p. 33-35 |
artikel |
8 |
Bone status in glucocorticoid-treated men and women
|
Leib, E. S. |
|
2015 |
27 |
1 |
p. 39-48 |
artikel |
9 |
Bone turnover markers: response to comments by Seeman and Nguyen
|
Naylor, K. E. |
|
2015 |
27 |
1 |
p. 37 |
artikel |
10 |
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation
|
Weaver, C. M. |
|
2015 |
27 |
1 |
p. 367-376 |
artikel |
11 |
Calcium, proton pump inhibitors, and fracture risk
|
Sugiyama, T. |
|
2015 |
27 |
1 |
p. 349-350 |
artikel |
12 |
Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study
|
Fink, H. A. |
|
2015 |
27 |
1 |
p. 331-338 |
artikel |
13 |
Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis
|
Silverman, S. L. |
|
2015 |
27 |
1 |
p. 75-80 |
artikel |
14 |
Cost-effectiveness of a fracture liaison service—a real-world evaluation after 6 years of service provision
|
Yong, J. H. E. |
|
2015 |
27 |
1 |
p. 231-240 |
artikel |
15 |
Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures
|
Ethgen, O. |
|
2015 |
27 |
1 |
p. 301-308 |
artikel |
16 |
Cost-effectiveness of vitamin D supplementation and exercise in preventing injurious falls among older home-dwelling women: findings from an RCT
|
Patil, R. |
|
2015 |
27 |
1 |
p. 193-201 |
artikel |
17 |
Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury
|
Gifre, L. |
|
2015 |
27 |
1 |
p. 405-410 |
artikel |
18 |
Diabetes mellitus and risk of hip fractures: a meta-analysis
|
Fan, Y. |
|
2015 |
27 |
1 |
p. 219-228 |
artikel |
19 |
Does salmon calcitonin cause cancer? A review and meta-analysis
|
Wells, G. |
|
2015 |
27 |
1 |
p. 13-19 |
artikel |
20 |
Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening
|
Pickhardt, P. J. |
|
2015 |
27 |
1 |
p. 147-152 |
artikel |
21 |
Effect of whole-body vibration training on bone mass in adolescents with and without Down syndrome: a randomized controlled trial
|
Matute-Llorente, A. |
|
2015 |
27 |
1 |
p. 181-191 |
artikel |
22 |
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study
|
Ebina, K. |
|
2015 |
27 |
1 |
p. 351-359 |
artikel |
23 |
Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients
|
Zhukouskaya, V. V. |
|
2015 |
27 |
1 |
p. 421 |
artikel |
24 |
Evaluation of a simplified hip structure analysis method for the prediction of incident hip fracture events
|
Khoo, B. C. C. |
|
2015 |
27 |
1 |
p. 241-248 |
artikel |
25 |
Evidence of a link between resting energy expenditure and bone remodelling, glucose homeostasis and adipokine variations in adolescent girls with anorexia nervosa
|
Maïmoun, L. |
|
2015 |
27 |
1 |
p. 135-146 |
artikel |
26 |
Fracture prediction from repeat BMD measurements in clinical practice
|
Leslie, W. D. |
|
2015 |
27 |
1 |
p. 203-210 |
artikel |
27 |
FRAX predicts incident falls in elderly men: findings from MrOs Sweden
|
Harvey, N. C. |
|
2015 |
27 |
1 |
p. 267-274 |
artikel |
28 |
Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre
|
Daruwalla, Z. J. |
|
2015 |
27 |
1 |
p. 361-366 |
artikel |
29 |
Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients
|
Madsen, C. M. |
|
2015 |
27 |
1 |
p. 397-404 |
artikel |
30 |
Low serum 25-hydroxyvitamin D is associated with increased risk of stress fracture during Royal Marine recruit training
|
Davey, T. |
|
2015 |
27 |
1 |
p. 171-179 |
artikel |
31 |
Meta-analysis of diabetes mellitus and risk of hip fractures: small-study effect
|
Nazarzadeh, M. |
|
2015 |
27 |
1 |
p. 229-230 |
artikel |
32 |
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
|
Eastell, R. |
|
2015 |
27 |
1 |
p. 309-318 |
artikel |
33 |
Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice
|
Oestreich, A. K. |
|
2015 |
27 |
1 |
p. 161-170 |
artikel |
34 |
Parity and osteoporotic fracture risk in postmenopausal women: a dose-response meta-analysis of prospective studies
|
Wang, Q. |
|
2015 |
27 |
1 |
p. 319-330 |
artikel |
35 |
Patients do not have a consistent understanding of high risk for future fracture: a qualitative study of patients from a post-fracture secondary prevention program
|
Sale, J. E. M. |
|
2015 |
27 |
1 |
p. 65-73 |
artikel |
36 |
Prevalence of sarcopenic obesity in Germany using established definitions
|
Kemmler, W. |
|
2015 |
27 |
1 |
p. 275-281 |
artikel |
37 |
Proton-pump inhibitors and risk of fractures: an update meta-analysis
|
Zhou, B. |
|
2015 |
27 |
1 |
p. 339-347 |
artikel |
38 |
Relationship between subclinical thyroid dysfunction and the risk of fracture: a meta-analysis of prospective cohort studies
|
Yan, Z. |
|
2015 |
27 |
1 |
p. 115-125 |
artikel |
39 |
Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
|
Naylor, K. E. |
|
2015 |
27 |
1 |
p. 21-31 |
artikel |
40 |
Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength
|
Yao, W. |
|
2015 |
27 |
1 |
p. 283-294 |
artikel |
41 |
Serotonergic antidepressant use and the risk of fracture: a population-based nested case–control study
|
Wang, C.-Y. |
|
2015 |
27 |
1 |
p. 57-63 |
artikel |
42 |
Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults
|
Olmos, J. M. |
|
2015 |
27 |
1 |
p. 105-113 |
artikel |
43 |
Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years
|
Thorin, M. H. |
|
2015 |
27 |
1 |
p. 249-255 |
artikel |
44 |
Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures
|
Scaglione, M. |
|
2015 |
27 |
1 |
p. 211-218 |
artikel |
45 |
The real enemy is fragility fracture, not osteoporosis
|
Uzoigwe, C. E. |
|
2015 |
27 |
1 |
p. 413-415 |
artikel |
46 |
The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials
|
Yuan, H.-f. |
|
2015 |
27 |
1 |
p. 295-299 |
artikel |
47 |
The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients
|
Zhukouskaya, V. V. |
|
2015 |
27 |
1 |
p. 49-56 |
artikel |
48 |
Towards better use of the net reclassification improvement (NRI) index
|
Leslie, W. D. |
|
2015 |
27 |
1 |
p. 411-412 |
artikel |
49 |
Trabecular bone score in type 1 diabetes—a cross-sectional study
|
Neumann, T. |
|
2015 |
27 |
1 |
p. 127-133 |
artikel |
50 |
Treatment of osteoporosis after alendronate or risedronate
|
Eiken, P. |
|
2015 |
27 |
1 |
p. 1-12 |
artikel |
51 |
Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study
|
Otaify, G. A. |
|
2015 |
27 |
1 |
p. 81-92 |
artikel |